Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (“TCM”) …
Regencell Bioscience Holdings Limited announces pricing of approximately $21.9 million initial public offering
